BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ding X, Zheng L, Yang B, Wang X, Ying Y. Luteolin Attenuates Atherosclerosis Via Modulating Signal Transducer And Activator Of Transcription 3-Mediated Inflammatory Response. Drug Des Devel Ther 2019;13:3899-911. [PMID: 31819365 DOI: 10.2147/DDDT.S207185] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Li R, Wang L, Liu S, Duan H, Zhang Q, Zhang T, Peng W, Huang Y, Wu C. Natural Flavonoids Derived From Fruits Are Potential Agents Against Atherosclerosis. Front Nutr 2022;9:862277. [DOI: 10.3389/fnut.2022.862277] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Zuo W, Liu N, Zeng Y, Xiao Z, Wu K, Yang F, Li B, Song Q, Xiao Y, Liu Q. Luteolin Ameliorates Experimental Pulmonary Arterial Hypertension via Suppressing Hippo-YAP/PI3K/AKT Signaling Pathway. Front Pharmacol 2021;12:663551. [PMID: 33935785 DOI: 10.3389/fphar.2021.663551] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xiong H, Dong Z, Lou G, Gan Q, Wang J, Huang Q. Analysis of the mechanism of Shufeng Jiedu capsule prevention and treatment for COVID-19 by network pharmacology tools. Eur J Integr Med 2020;40:101241. [PMID: 33520015 DOI: 10.1016/j.eujim.2020.101241] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Tao Y, Zhu F, Pan M, Liu Q, Wang P. Pharmacokinetic, Metabolism, and Metabolomic Strategies Provide Deep Insight Into the Underlying Mechanism of Ginkgo biloba Flavonoids in the Treatment of Cardiovascular Disease. Front Nutr 2022;9:857370. [DOI: 10.3389/fnut.2022.857370] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Syahputra RA, Harahap U, Dalimunthe A, Nasution MP, Satria D. The Role of Flavonoids as a Cardioprotective Strategy against Doxorubicin-Induced Cardiotoxicity: A Review. Molecules 2022;27:1320. [PMID: 35209107 DOI: 10.3390/molecules27041320] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
6 Zhang F, Liu P, He Z, Zhang L, He X, Liu F, Qi J. Crocin ameliorates atherosclerosis by promoting the reverse cholesterol transport and inhibiting the foam cell formation via regulating PPARγ/LXR-α. Cell Cycle 2022;:1-17. [PMID: 34978526 DOI: 10.1080/15384101.2021.2015669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Taheri Y, Sharifi-Rad J, Antika G, Yılmaz YB, Tumer TB, Abuhamdah S, Chandra S, Saklani S, Kılıç CS, Sestito S, Daştan SD, Kumar M, Alshehri MM, Rapposelli S, Cruz-Martins N, Cho WC. Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits. Oxid Med Cell Longev 2021;2021:1987588. [PMID: 34594472 DOI: 10.1155/2021/1987588] [Reference Citation Analysis]
8 Rajendran P, Alzahrani AM, Ahmed EA, Veeraraghavan VP. Kirenol Inhibits B[a]P-Induced Oxidative Stress and Apoptosis in Endothelial Cells via Modulation of the Nrf2 Signaling Pathway. Oxid Med Cell Longev 2021;2021:5585303. [PMID: 33981385 DOI: 10.1155/2021/5585303] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 De Stefano A, Caporali S, Di Daniele N, Rovella V, Cardillo C, Schinzari F, Minieri M, Pieri M, Candi E, Bernardini S, Tesauro M, Terrinoni A. Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside. Int J Mol Sci 2021;22:1321. [PMID: 33525692 DOI: 10.3390/ijms22031321] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Toma L, Sanda GM, Niculescu LS, Deleanu M, Sima AV, Stancu CS. Phenolic Compounds Exerting Lipid-Regulatory, Anti-Inflammatory and Epigenetic Effects as Complementary Treatments in Cardiovascular Diseases. Biomolecules 2020;10:E641. [PMID: 32326376 DOI: 10.3390/biom10040641] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
11 Casili G, Ardizzone A, Lanza M, Gugliandolo E, Portelli M, Militi A, Cuzzocrea S, Esposito E, Paterniti I. Treatment with Luteolin Improves Lipopolysaccharide-Induced Periodontal Diseases in Rats. Biomedicines 2020;8:E442. [PMID: 33096800 DOI: 10.3390/biomedicines8100442] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]